edoxaban and gw813893 share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.667 means 67% of the combined target set is bound by both compounds. The IDF-weighted score of 0.622 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do edoxaban and gw813893 have in common?
edoxaban and gw813893 share 2 molecular targets with a Jaccard similarity of 67%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can edoxaban and gw813893 be combined?
edoxaban and gw813893 share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: edoxaban or gw813893?
In the BiohacksAI corpus: edoxaban has 0 PubMed-indexed studies, gw813893 has 0 studies.